参考文献/References:
[1] Nichols WL,Hultin MB,James AH,et al.von Willebrand disease(VWD):evidence-based diagnosis and management guidelines,the National Heart,Lung,and Blood Istitute(NHLBI)Expert Panel report(USA)[J].Haemophilia,2008,14(2):171-232.
[2] Laffan M,Brown SA,Collins PW,et al.The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors'Organization[J].Haemophilia,2004,10(3):199-217.
[3] 中华医学会血液学分会血栓与止血组.血管性血友病诊断与治疗中国专家共识(2012版)[J].中华血液学杂志,2012,33(11):980-981.
Transfusion and Hematology Branch of Chinese Medical Association.The diagnosis and treatment of von Willebrand Disease:The Chinese expert experience(2012 edition)[J].Chinese Journal of Hematology,2012,33(11):980-981.
[4] 赵海建,周伟燕,张传宝,等.血清总胆固醇测定的基质效应研究[J].现代检验医学杂志,2009,24(3):5-9.
Zhao HJ,Zhou WY,Zhang CB,et al.Evaluation of matrix effect of processed materials in serum total cholesterol measurements[J].Journal of Modern Laboratory Medicine,2009,24(3):5-9.
[5] 中国合格评定国家认可委员会CNAS-GL03.能力验证样本均匀性和稳定性评价指南[S].北京:中国合格评定国家认可委员会CNAS-GL03,2006.
China National Accreditation Service for Conformity Assessment.CNAS-GL03.Guidance on evaluating the homogeneity and stability of samples used forproficiency testing[S].Beijing:CNAS-GL03,2006.
[6] ISO Guide 35.Reference materials-General and Statistical principles forcertification[S].Switzerland:Geneva,ISO Guide 35,2006.
[7] 中华人民共和国国家卫生和计划生育委员会.WS/T 356-2011基质效应与互通性评估指南[S].北京:中国标准出版社,2011.
National Health and Family Planning Commission of the People's Republic of China.WS/T 356-2011.Guidance on matrix effects and interoperability evaluation[S].Beijing:China Standard Publishing House,2011.
[8] 彭明婷,艾承锦,李臣宾,等.氰化高铁血红蛋白国家一级标准物质的研制[J].中华检验医学杂志,2009,32(1):97-101.
Peng MT,Ai CJ,Li CB,et al.Establishment of the national standardmaterials for haemiglobincyanide[J].Chin J Lab Med,2009,32(1):97-101.
[9] 彭明婷,谷小林,李臣宾,等.血细胞分析国家一级标准物质的研制[J].临床输血与检验,2012,14(1):1-5.
Peng MT,Gu XL,Li CB,et al.Preparation of primary reference material for blood cell count[J].Journal of Clinical Transfusion and Laboratory Medicine,2012,14(1):1-5.
[10] 李臣宾,谷小林,彭明婷,等.红细胞比容国家一级标准物质的研制[J].临床输血与检验,2014,16(1):1-4.
Li CB,Gu XL,Peng MT,et al.Preparation of primary reference material for hematocrit[J]. Journal of Clinical Transfusion and Laboratory Medicine,2014,16(1):1-4.
相似文献/References:
[1]李炳奇,叶俊伟,梅喜平,等.脓毒症患者血液激活素 a,CRP,HMGB1和 vWF表达水平及临床意义[J].现代检验医学杂志,2022,37(01):97.[doi:10.3969/j.issn.1671-7414.2022.01.020]
LI Bing-qi,YE Jun-wei,MEI Xi-ping,et al.Blood Activator A, CRP, HMGB1 and vWF Expression Levels and Clinical Significance in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(03):97.[doi:10.3969/j.issn.1671-7414.2022.01.020]